Global Intravenous General Anesthetics Market Growth 2023-2029
The global Intravenous General Anesthetics market size is projected to grow from US$ 5439.1 million in 2022 to US$ 7070 million in 2029; it is expected to grow at a CAGR of 3.8% from 2023 to 2029.
United States market for Intravenous General Anesthetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Intravenous General Anesthetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Intravenous General Anesthetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Intravenous General Anesthetics players cover AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B. Braun Melsungen, Liaoning Haisco, Pfizer, Teva Pharmaceutical Industries and Fresenius Kabi AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Intravenous anesthesia is administered through a vein to provide general anesthesia.
LPI (LP Information)' newest research report, the “Intravenous General Anesthetics Industry Forecast” looks at past sales and reviews total world Intravenous General Anesthetics sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous General Anesthetics sales for 2023 through 2029. With Intravenous General Anesthetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous General Anesthetics industry.
This Insight Report provides a comprehensive analysis of the global Intravenous General Anesthetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous General Anesthetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intravenous General Anesthetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous General Anesthetics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous General Anesthetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous General Anesthetics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Sedative
Analgesics
Muscle Relaxants
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B. Braun Melsungen
Liaoning Haisco
Pfizer
Teva Pharmaceutical Industries
Fresenius Kabi AG
SGPharma
Jiangsu Nhua Pharmaceutical Co., Ltd.
Xi'an Libang Pharmaceutical Co., Ltd.
Baxter international
Sichuan Guorui Pharmaceutical Co., Ltd.
Hikma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intravenous General Anesthetics market?
What factors are driving Intravenous General Anesthetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous General Anesthetics market opportunities vary by end market size?
How does Intravenous General Anesthetics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.